Renewed activity in "The Prajs-Drimmer Institute for the Development of Anti-Degenerative Drugs"

Since its establishment in 2007, the Prajs-Drimmer Institute for the Development of Anti-Degenerative Drugs has pursued a range of activities aimed at deepening knowledge of neurodegenerative diseases and cancer. Now, to substantially intensify the activity and impact of the Institute, Dr. h. c. Sruel Prajs and Board of Governors member Norma Drimmer, have provided a generous new gift toward the Institute.  This gift will  boost the Institute’s capacity to accelerate the pace of research and discovery, enhance its scientific standing, promote multidisciplinary research, and nurture a new generation of scientists to lead and shape the field in the coming years.